Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Danny S. C. Ng, Mary Ho, Lawrence P.L. Iu & Timothy Y.Y. Lai. (2022) Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization. Expert Opinion on Drug Safety 21:1, pages 43-54.
Read now
Read now
Amber T. Wolf, Alon Harris, Francesco Oddone, Brent Siesky, Alice Verticchio Vercellin & Thomas A. Ciulla. (2022) Disease progression pathways of wet AMD: opportunities for new target discovery. Expert Opinion on Therapeutic Targets 26:1, pages 5-12.
Read now
Read now
Marc Schargus & Andreas Frings. (2020) Issues with Intravitreal Administration of Anti-VEGF Drugs. Clinical Ophthalmology 14, pages 897-904.
Read now
Read now
Rehan M. Hussain, Christina Y. Weng, Charles C. Wykoff, Raya A. Gandhi & Seenu M. Hariprasad. (2020) Abicipar pegol for neovascular age-related macular degeneration. Expert Opinion on Biological Therapy 20:9, pages 999-1008.
Read now
Read now
Volkan Yeter, Özlem Eşki Yücel & Hakkı Birinci. (2020) The Short-Term Efficacy of Biweekly Subconjunctival Bevacizumab in Diabetic Macular Edema. Current Eye Research 45:5, pages 585-590.
Read now
Read now
Richard Filek, Phil Hooper, Tom G Sheidow, John Gonder, Subrata Chakrabarti & Cindy ML Hutnik. (2019) Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients. Clinical Ophthalmology 13, pages 1087-1096.
Read now
Read now
Hasenin Al-Khersan, Rehan M. Hussain, Thomas A. Ciulla & Pravin U. Dugel. (2019) Innovative therapies for neovascular age-related macular degeneration. Expert Opinion on Pharmacotherapy 20:15, pages 1879-1891.
Read now
Read now
Rehan M Hussain & Thomas A. Ciulla. (2017) Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration. Expert Opinion on Emerging Drugs 22:3, pages 235-246.
Read now
Read now
Articles from other publishers (16)
José Edísio da Silva Tavares Neto, Francyne Veiga Reis Cyrino, Moises Moura Lucena, Ingrid U. Scott, André Márcio Vieira Messias & Rodrigo Jorge. (2023) Intravitreal bevacizumab plus propranolol for neovascular age-related macular degeneration (the BEVALOL study): a phase I clinical trial. International Journal of Retina and Vitreous 9:1.
Crossref
Crossref
Zhan Xie, Xin-jing Wu, Rui-wen Cheng, Jia-hua Cui, Song-tao Yuan, Jian-wei Zhou & Qing-huai Liu. (2022) JP1, a polypeptide specifically targeting integrin αVβ3, ameliorates choroidal neovascularization and diabetic retinopathy in mice. Acta Pharmacologica Sinica 44:4, pages 897-912.
Crossref
Crossref
Rongyuan Chen, Juanhua Zhu, Jiaxin Hu & Xuri Li. (2023) Antiangiogenic therapy for ocular diseases: Current status and challenges. MedComm – Future Medicine 2:1.
Crossref
Crossref
Betul Onal Gunay & Cenap Mahmut Esenulku. (2022) Corneal biomechanical assessment via ocular response analyzer following intravitreal aflibercept therapyBiomechanische Beurteilung der Hornhaut nach intravitrealer Aflibercept-Therapie mit dem Ocular Response Analyzer. Spektrum der Augenheilkunde 37:1, pages 22-28.
Crossref
Crossref
Cengiz Türksever, Laura Hoffmann & Katja Hatz. (2023) Peripapillary and macular microvasculature in neovascular age-related macular degeneration in long-term and recently started anti-VEGF therapy versus healthy controls. Frontiers in Medicine 9.
Crossref
Crossref
Moustafa Hamam, Neil Lagali, Elie Abdulnour, Helen Setterud, Björn Johansson & Pierfrancesco Mirabelli. (2022) Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to Pro Re Nata or Treat-and-Extend Regimen in Eyes with or without Epiretinal Membrane. Journal of Ophthalmology 2022, pages 1-10.
Crossref
Crossref
Josephine En Hui Lee, Suresh Subramanian, Adil Hussein, Kursiah Mohd Razali & Qi Zhe Ngoo. (2022) Changes of Ocular Biometry and Intraocular Pressure in Patients Treated With Intravitreal Injection of Antivascular Endothelial Growth Factors. Malaysian Journal of Medicine and Health Sciences 18:5, pages 144-150.
Crossref
Crossref
Nadhini Arumuganathan, Maximilian Robert Justus Wiest, Mario Damiano Toro, Timothy Hamann, Katrin Fasler & Sandrine Anne Zweifel. (2021) Acute and subacute macular and peripapillary angiographic changes in choroidal and retinal blood flow post-intravitreal injections. Scientific Reports 11:1.
Crossref
Crossref
Alicia Pareja-Ríos, Elena de Armas-Ramos, Ana Aldea-Perona & Sergio Bonaque-González. (2021) Alone laser versus bevacizumab plus laser for diffuse diabetic macular edema (ALBA randomized trial). Therapeutic Advances in Ophthalmology 13, pages 251584142098821.
Crossref
Crossref
Ronaldo Nuesi & Swarup S. Swaminathan. (2020) Effect of Intravitreal Injections on Retinal Imaging Metrics in Glaucomatous and Non-Glaucomatous Eyes. Current Ophthalmology Reports 8:3, pages 111-119.
Crossref
Crossref
Qi N. Cui, Iga N. Gray, Yinxi Yu & Brian L. VanderBeek. (2019) Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use. Graefe's Archive for Clinical and Experimental Ophthalmology 257:9, pages 1931-1939.
Crossref
Crossref
I. Leleu, B. Penaud, E. Blumen-Ohana, T. Rodallec, R. Adam, O. Laplace, J. Akesbi & J.-P. Nordmann. (2018) Hypertonie intraoculaire retardée liée aux injections intra-vitréennes répétées d’anti-VEGF : des cas nécessitant une chirurgie filtrante. Journal Français d'Ophtalmologie 41:9, pages 789-801.
Crossref
Crossref
Marc Schargus, Benjamin P. WernerGerd GeerlingGerhard Winter. (2018) CONTAMINATION OF ANTI-VEGF DRUGS FOR INTRAVITREAL INJECTION. Retina 38:10, pages 2088-2095.
Crossref
Crossref
I. Leleu, B. Penaud, E. Blumen-Ohana, T. Rodallec, R. Adam, O. Laplace, J. Akesbi & J.-P. Nordmann. (2018) Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: Cases requiring filtering surgery. Journal Français d'Ophtalmologie 41:8, pages e329-e340.
Crossref
Crossref
Peter Bracha, Nicholas A. Moore, Thomas A. Ciulla, Darrell WuDunn & Louis B. Cantor. (2018) The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review. Survey of Ophthalmology 63:3, pages 281-295.
Crossref
Crossref
S. Vo Kim, F. Fajnkuchen, V. Sarda, L. Qu-Knafo, B. Bodaghi & A. Giocanti-Aurégan. (2017) Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a real-life setting. Graefe's Archive for Clinical and Experimental Ophthalmology 255:11, pages 2165-2171.
Crossref
Crossref